Full Episode
Thursday, May 21
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
    • Compass Points
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Horizons
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

FDA

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
Department of Health and Human Services announces new guidance for individualized drug and biological therapies

Health May 12

Marty Makary resigns as Trump's FDA chief

By Matthew Perrone, Seung Min Kim, Associated Press

Politics May 11

Abortion Pill Politics
Supreme Court temporarily extends access to a widely used abortion pill

The Supreme Court is leaving women’s access to a widely used abortion pill untouched until at least Thursday, while the justices consider whether to allow restrictions on the drug, mifepristone, to take effect.

By Mark Sherman, Geoff Mulvihill, Matthew Perrone, Associated Press

Nation May 08

U.S. Health and Human Services (HHS) Secretary Robert F.Kennedy, Jr. and U.S. Food and Drug Administration (FDA) Commissio...
Watch 7:10
Why FDA Commissioner Makary is on the ropes after months of turmoil

Multiple outlets are reporting that Trump is set to fire Food and Drug Administration Commissioner Marty Makary. The news comes after a tumultuous tenure since his installment as FDA head last year. Stephanie Sy speaks with Liz Whyte, health policy…

By Stephanie Sy, Courtney Norris

Health Apr 23

Denver during the annual but informal cannabis holiday, 4/20 (four-twenty)
Watch 4:04
What marijuana's reclassification means for public health and businesses

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less potential for harm. While this doesn’t legalize marijuana nationally, it does open the door for further research into its effects. William Brangham…

By William Brangham, Jonah Anderson

Health Apr 01

Eli Lilly-Weight-Loss-Pill
FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.

By JoNel Aleccia, Associated Press

Mar 29

Makers of dietary supplements push the FDA to allow peptides and other new ingredients

By Matthew Perrone, Associated Press

Makers of dietary supplements are pushing the Food and Drug Administration to expand the types of ingredients they can put in their products.

Continue reading

Mar 14

What are peptides, and are they safe? Here's what to know

By Grace Abels, PolitiFact

Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.

Continue reading

Mar 10

FDA finds little evidence that the generic drug leucovorin can help people with autism

By Matthew Perrone, Associated Press

FDA officials say evidence only supports the drug's use in patients with a specific genetic disorder.

Continue reading

Mar 09

Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration

By Michelle Chapman, Associated Press

The companies on Monday announced a partnership in which Hims & Hers will sell Novo Nordisk's medications at "self-pay prices."…

Continue reading

Jan 18

FDA's new expedited drug program raises legal questions and concerns

By Matthew Perrone, Associated Press

The FDA commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency.

Continue reading

Jump to the First Page Previous Page
1 2 3 4 5 6 7 8 9 36
Next Page Jump to the Last Page

Support Provided By: Learn more

Evergreen_WebAd_Sidebar_DonateNow

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Thursday, May 21
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Friends of the News Hour
PBS News

© 1996 - 2026 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You